US Stock MarketDetailed Quotes

IOBT IO Biotech

Watchlist
  • 1.460
  • -0.010-0.68%
Close Apr 24 16:00 ET
96.19MMarket Cap-737P/E (TTM)

IO Biotech Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
28.03%91.44M
38.23%28.18M
48.02%23.48M
20.32%21.85M
5.37%17.92M
73.22%71.42M
-4.70%20.39M
125.29%15.87M
102.17%18.16M
346.11%17.01M
Selling and administrative expenses
-3.37%23.61M
7.67%6.41M
-0.24%5.83M
-9.89%5.35M
-10.14%6.02M
120.52%24.44M
20.20%5.96M
100.51%5.84M
164.01%5.94M
594.72%6.7M
-General and administrative expense
-3.37%23.61M
7.67%6.41M
-0.24%5.83M
-9.89%5.35M
-10.14%6.02M
120.52%24.44M
20.20%5.96M
100.51%5.84M
164.01%5.94M
594.72%6.7M
Research and development costs
44.36%67.83M
50.83%21.77M
76.16%17.66M
34.99%16.5M
15.47%11.9M
55.83%46.99M
-12.21%14.43M
142.78%10.02M
81.53%12.23M
261.87%10.31M
Operating profit
-28.03%-91.44M
-38.23%-28.18M
-48.02%-23.48M
-20.32%-21.85M
-5.37%-17.92M
-73.22%-71.42M
4.70%-20.39M
-125.29%-15.87M
-102.17%-18.16M
-346.11%-17.01M
Net non-operating interest income expense
430.30%5.88M
148.91%1.95M
350.66%1.71M
2,035.71%1.2M
1,051.85%1.03M
407.20%1.11M
618.54%783K
665.67%379K
178.87%56K
-50.00%-108K
Non-operating interest income
316.80%5.88M
149.87%1.95M
273.74%1.71M
656.96%1.2M
6,753.33%1.03M
--1.41M
--780K
--457K
--158K
--15K
Non-operating interest expense
--0
--0
--0
--0
--0
-16.34%302K
-101.99%-3K
16.42%78K
43.66%102K
70.83%123K
Other net income (expense)
154.62%331K
-22.41%405K
-293.10%-342K
103.50%10K
1,390.00%258K
100.50%130K
71.15%522K
-103.29%-87K
99.02%-286K
-114.60%-20K
Gain on sale of security
154.62%331K
-22.41%405K
-293.10%-342K
103.50%10K
1,390.00%258K
-59.25%130K
5,120.00%522K
-611.76%-87K
-284.52%-286K
-114.60%-20K
Income before tax
-21.44%-85.23M
-35.34%-25.83M
-42.03%-22.12M
-12.26%-20.65M
2.92%-16.64M
-3.50%-70.19M
10.15%-19.08M
-249.01%-15.57M
52.06%-18.39M
-357.26%-17.14M
Income tax
-33.07%852K
-64.24%353K
-481.74%-439K
411.54%532K
515.15%406K
1,772.06%1.27M
1,351.47%987K
115K
104K
66K
Net income
-20.47%-86.08M
-30.45%-26.18M
-38.19%-21.68M
-14.51%-21.18M
0.93%-17.04M
-5.27%-71.46M
5.81%-20.07M
-251.59%-15.69M
51.78%-18.5M
-359.02%-17.2M
Net income continuous Operations
-20.47%-86.08M
-30.45%-26.18M
-38.19%-21.68M
-14.51%-21.18M
0.93%-17.04M
-5.27%-71.46M
5.81%-20.07M
-251.59%-15.69M
51.78%-18.5M
-359.02%-17.2M
Minority interest income
Net income attributable to the parent company
-20.47%-86.08M
-30.45%-26.18M
-38.19%-21.68M
-14.51%-21.18M
0.93%-17.04M
-5.27%-71.46M
5.81%-20.07M
-251.59%-15.69M
51.78%-18.5M
-359.02%-17.2M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-20.47%-86.08M
-30.45%-26.18M
-38.19%-21.68M
-14.51%-21.18M
0.93%-17.04M
4.71%-71.46M
10.44%-20.07M
-140.06%-15.69M
54.28%-18.5M
-207.93%-17.2M
Basic earnings per share
20.16%-1.98
43.23%-0.3974
20.37%-0.43
-15.63%-0.74
1.67%-0.59
85.66%-2.48
10.00%-0.7
-112.59%-0.54
81.73%-0.64
-24.02%-0.6
Diluted earnings per share
20.16%-1.98
43.23%-0.3974
20.37%-0.43
-15.63%-0.74
1.67%-0.59
85.66%-2.48
10.00%-0.7
-112.59%-0.54
81.73%-0.64
-24.02%-0.6
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 28.03%91.44M38.23%28.18M48.02%23.48M20.32%21.85M5.37%17.92M73.22%71.42M-4.70%20.39M125.29%15.87M102.17%18.16M346.11%17.01M
Selling and administrative expenses -3.37%23.61M7.67%6.41M-0.24%5.83M-9.89%5.35M-10.14%6.02M120.52%24.44M20.20%5.96M100.51%5.84M164.01%5.94M594.72%6.7M
-General and administrative expense -3.37%23.61M7.67%6.41M-0.24%5.83M-9.89%5.35M-10.14%6.02M120.52%24.44M20.20%5.96M100.51%5.84M164.01%5.94M594.72%6.7M
Research and development costs 44.36%67.83M50.83%21.77M76.16%17.66M34.99%16.5M15.47%11.9M55.83%46.99M-12.21%14.43M142.78%10.02M81.53%12.23M261.87%10.31M
Operating profit -28.03%-91.44M-38.23%-28.18M-48.02%-23.48M-20.32%-21.85M-5.37%-17.92M-73.22%-71.42M4.70%-20.39M-125.29%-15.87M-102.17%-18.16M-346.11%-17.01M
Net non-operating interest income expense 430.30%5.88M148.91%1.95M350.66%1.71M2,035.71%1.2M1,051.85%1.03M407.20%1.11M618.54%783K665.67%379K178.87%56K-50.00%-108K
Non-operating interest income 316.80%5.88M149.87%1.95M273.74%1.71M656.96%1.2M6,753.33%1.03M--1.41M--780K--457K--158K--15K
Non-operating interest expense --0--0--0--0--0-16.34%302K-101.99%-3K16.42%78K43.66%102K70.83%123K
Other net income (expense) 154.62%331K-22.41%405K-293.10%-342K103.50%10K1,390.00%258K100.50%130K71.15%522K-103.29%-87K99.02%-286K-114.60%-20K
Gain on sale of security 154.62%331K-22.41%405K-293.10%-342K103.50%10K1,390.00%258K-59.25%130K5,120.00%522K-611.76%-87K-284.52%-286K-114.60%-20K
Income before tax -21.44%-85.23M-35.34%-25.83M-42.03%-22.12M-12.26%-20.65M2.92%-16.64M-3.50%-70.19M10.15%-19.08M-249.01%-15.57M52.06%-18.39M-357.26%-17.14M
Income tax -33.07%852K-64.24%353K-481.74%-439K411.54%532K515.15%406K1,772.06%1.27M1,351.47%987K115K104K66K
Net income -20.47%-86.08M-30.45%-26.18M-38.19%-21.68M-14.51%-21.18M0.93%-17.04M-5.27%-71.46M5.81%-20.07M-251.59%-15.69M51.78%-18.5M-359.02%-17.2M
Net income continuous Operations -20.47%-86.08M-30.45%-26.18M-38.19%-21.68M-14.51%-21.18M0.93%-17.04M-5.27%-71.46M5.81%-20.07M-251.59%-15.69M51.78%-18.5M-359.02%-17.2M
Minority interest income
Net income attributable to the parent company -20.47%-86.08M-30.45%-26.18M-38.19%-21.68M-14.51%-21.18M0.93%-17.04M-5.27%-71.46M5.81%-20.07M-251.59%-15.69M51.78%-18.5M-359.02%-17.2M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -20.47%-86.08M-30.45%-26.18M-38.19%-21.68M-14.51%-21.18M0.93%-17.04M4.71%-71.46M10.44%-20.07M-140.06%-15.69M54.28%-18.5M-207.93%-17.2M
Basic earnings per share 20.16%-1.9843.23%-0.397420.37%-0.43-15.63%-0.741.67%-0.5985.66%-2.4810.00%-0.7-112.59%-0.5481.73%-0.64-24.02%-0.6
Diluted earnings per share 20.16%-1.9843.23%-0.397420.37%-0.43-15.63%-0.741.67%-0.5985.66%-2.4810.00%-0.7-112.59%-0.5481.73%-0.64-24.02%-0.6
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg